Frontier Medicines to Present at the Cantor Global Healthcare Conference SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...

Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline         —Funding to Enhance Research and Development of Pipeline, Including Lead Program Targeting Activated KRASG12C— —Proceeds to Further Accelerate the Development of Foundational Technologies in...